Gene Expression Analysis in Pancreatic Cancer Patients
Author Information
Author(s): Baine Michael J., Chakraborty Subhankar, Smith Lynette M., Mallya Kavita, Sasson Aaron R., Brand Randall E., Batra Surinder K.
Primary Institution: University of Nebraska Medical Center
Hypothesis
An alteration in the global gene expression profile of PBMCs occurs in patients with pancreatic cancer.
Conclusion
The study identifies a gene predictor set that can potentially be developed for diagnostic use in pancreatic cancer.
Supporting Evidence
- 383 genes were found to be significantly different between pancreatic cancer patients and healthy controls.
- An eight-gene predictor set was identified that could distinguish pancreatic cancer patients from healthy controls with 79% accuracy.
- The study highlights the potential for PBMC gene expression profiling as a diagnostic tool for pancreatic cancer.
Takeaway
Researchers looked at blood cells from pancreatic cancer patients and found specific genes that could help detect the disease early.
Methodology
PBMC samples from 26 pancreatic cancer patients and 33 matched healthy controls were analyzed using whole genome cDNA microarray.
Potential Biases
Potential biases may arise from the selection of matched controls and the variability in gene expression.
Limitations
The study's sample size is relatively small, and further validation in larger cohorts is needed.
Participant Demographics
{"gender":{"male":13,"female":13},"age":{"mean":64.4,"sd":9.0},"race":{"caucasian":21,"non_caucasian":3}}
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website